Schizophrenia is one of the most challenging brain disorders a mental health professional can face, yet its causes and cure remain elusive. Written by experts from a wide range of psychiatric disciplines to serve as a singular resource, Essentials of Schizophrenia clearly defines the current knowledge of the nature, causes, and treatment of this disorder and puts the many misconceptions about this disabling illness into perspective.
Schizophrenia is so devastating because it robs people of the very things that make them human -- their personality and intellect. Symptoms typically have their onset in early adulthood, and the disorder often leaves the individual permanently disabled. This book leads readers through questions surrounding this debilitating disorder, from an historical overview and review of epidemiology to consideration of comorbid conditions. Key topics covered in this text include: Identification of early signs of cognitive impairment and the resulting psychopharmalogical treatment strategies for improving social or vocational function.
Role of antipsychotics, antianxiety/hypnotics, antidepressants, mood stabilizers, and dopamine agonists in treatment and associated side effects.
Current proven psychosocial interventions that augment and complement drug therapy, and increased patient involvement in choice of treatment modality.
Keys to early identification of individuals who are vulnerable to schizophrenia, and the potential for earlier intervention and treatment.
Optimal treatment approaches for first episodes to increase the likelihood of full recovery.
Answers to frequently asked questions raised by psychiatrists in daily encounters with their patients with schizophrenia.
A must-read for anyone involved in the care and treatment of individuals with schizophrenia, Essentials of Schizophrenia helps the reader better understand the disorderin an accessible format. Squarely confronting a misunderstood disease that has caused great suffering and disability, this textbook serves as a dependable source of knowledge for current psychiatric professionals as well as the next generation of students and clinicians to come.
Jeffrey A. Lieberman, M.D., is Chairman of the Department of Psychiatry at the College of Physicians and Surgeons of Columbia University, Director of the New York State Psychiatric Institute, and Psychiatrist-in-Chief at New York Presbyterian Hospital-Columbia University Medical Center in New York, New York. T. Scott Stroup, M.D., M.P.H., is Director of the Program for Intervention Effectiveness Research and Associate Director for Adult Services in the Division of Mental Health Services and Policy Research at New York State Psychiatric Institute, Department of Psychiatry of the College of Physicians and Surgeons of Columbia University in New York, New York. Diana O. Perkins, M.D., M.P.H., is Professor and Medical Director of OASIS (Outreach and Support Intervention Services) in the Department of Psychiatry at the University of North Carolina-Chapel Hill School of Medicine in Chapel Hill, North Carolina.
ContributorsPrefaceChapter 1. Epidemiology and Natural HistoryChapter 2. PsychopathologyChapter 3. Prodrome and First EpisodeChapter 4. Neurocognitive ImpairmentsChapter 5. Social and Functional ImpairmentsChapter 6. Co-occurring Substance Use and Other Psychiatric DisordersChapter 7. Medical ComorbiditiesChapter 8. PharmacotherapiesChapter 9. Psychosocial TherapiesChapter 10. Treatment of Chronic SchizophreniaIndex